Array
(
)
1
		

Kinase Inhibitors

Bimiralisib View larger

Bimiralisib

AT2265

CAS 1225037-39-7

More details

1000 Items

Molarity Calculation Cart®

HOW TO ORDER

$31.00

$31.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
15 $26.35 Total: $131.75
110 $22.32 Total: $223.20
125 $18.91 Total: $472.75
150 $16.12 Total: $806.00
1100 $13.95 Total: $1,395.00

Data sheet

Molecular FormulaC17H20F3N7O2
Molecular Weight411.38
CAS Numbers1225037-39-7
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeNc1cc(c(cn1)-c1nc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F
ReferencesBeaufils F, et al. 5-[4,6-Dimorpholino-1,3,5-triazin-2-yl]-4-[trifluoromethyl]pyridin-2-amine [PQR309], a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3KmTOR Inhibitor as Clinical Candidate in Oncology. J Med Chem. 2017 Sep 14;60[17] 7524-7538.

More info

Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha, beta, gamma and delta and, to a lesser extent, mTOR kinase, which may result in tumor cell apoptosis and growth inhibition in cells overexpressing PI3KmTOR. Activation of the PI3KmTOR pathway promotes cell growth, survival, and resistance to both chemotherapy and radiotherapy.